Quarterly report pursuant to Section 13 or 15(d)

DISCONTINUED OPERATIONS (Tables)

v3.23.1
DISCONTINUED OPERATIONS (Tables)
 3 Months Ended
Mar. 31, 2023
Discontinued Operations and Disposal Groups [Abstract]  
SCHEDULE OF COMPONENTS OF ASSETS AND LIABILITIES AND REVENUE CLASSIFIED AS DISCONTINUED OPERATIONS

The table below presents the significant components of its former Pharma Solutions business unit’s results included within loss from discontinued operations, net of tax in the condensed consolidated statements of operations for the three- months ended March 31, 2023 and 2022.

  

    2023     2022  
    For The Three Months Ended  
    March 31,  
    2023     2022  
       
Revenue, net   $ -     $ 2,454  
                 
Loss from discontinued operations     -       (1,058 )
Income tax expense     79       54  
Loss from discontinued operations, net of tax   $ (79 )   $ (1,112 )

 

Cash used from discontinued operations, operating activities, for the three months ended March 31, 2022 was approximately $1.1 million. There was no cash flow activity from discontinued operations for the three months ended March 31, 2023. Depreciation and amortization expense within discontinued operations for the three months ended March 31, 2022 was $0.4 million. There was no depreciation and amortization expense for the three months ended March 31, 2023.